trimetazidine has been researched along with Alloxan Diabetes in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Erbaş, O; Erdoğan, MA; Gölboyu, BE | 1 |
| Abdel-Rahman, RF; Khattab, MM; Mahmoud, SS; Mohamed, MAE; Safar, MM | 1 |
| Li, T; Shao, S; Xu, Q; Yang, Y | 1 |
| Breedt, E; Essop, MF; Lacerda, L | 1 |
| Ahangarpour, A; Badavi, M; Dianat, M; Mard, SA; Ramezani-Aliakbari, F | 2 |
| Mansur, AJ | 1 |
| Akdemir, O; Ates, U; Cavusoğlu, T; Erbas, O; Karadeniz, M; Karadeniz, T; Tuglu, MI; Turkmen, E; Uyanıkgil, Y | 1 |
| Ding, WY; Li, Y; Tang, MX; Wang, F; Wang, ZH; Zhang, L; Zhang, W; Zhang, Y; Zhong, M | 1 |
| Akbulut, Z; Altinova, S; Altintas, R; Celik, HT; Ener, K; Hekimoglu, ER; Namuslu, M; Ozcan, MF | 1 |
| Shen, JX; Wang, F; Wang, YM; Yu, P; Zhang, RY | 1 |
| Cho, BJ; Choi, SH; Jang, HC; Kang, SM; Kim, YB; Lee, MJ; Lim, S; Park, HS; Park, KS; Shin, H; Yoon, JW | 1 |
| Deng, SB; He, L; She, Q; Xia, S; Xiang, YL; Xiao, J; Xiu, Y | 1 |
| Bescond-Jacquet, A; Grynberg, A; Ovide-Bordeaux, S | 1 |
| Batmaz, B; Dernek, S; Erkasap, N; Ikizler, M; Kaygisiz, Z; Kural, T | 1 |
| Altan, VM; Arioglu, E; Guner, S; Onay-Besikci, A; Ozakca, I; Ozcelikay, AT | 1 |
16 other study(ies) available for trimetazidine and Alloxan Diabetes
| Article | Year |
|---|---|
Trimetazidine provides protection against diabetic polyneuropathy in rats via modulation of soluble HMGB1.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; HMGB1 Protein; Rats; Rats, Sprague-Dawley; Trimetazidine | 2023 |
Metformin and trimetazidine ameliorate diabetes-induced cognitive impediment in status epileptic rats.
Topics: Administration, Oral; Animals; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Hippocampus; Hypoglycemic Agents; Inflammation Mediators; Male; Metformin; NF-kappa B; Rats; Rats, Wistar; Trimetazidine; Vasodilator Agents | 2020 |
Trimetazidine ameliorates hindlimb ischaemic damage in type 2 diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Hindlimb; Humans; Intercellular Adhesion Molecule-1; Ischemia; Lower Extremity; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Peripheral Arterial Disease; Trimetazidine; Vascular Endothelial Growth Factor A | 2021 |
Trimetazidine therapy for diabetic mouse hearts subjected to ex vivo acute heart failure.
Topics: Acute Disease; Animals; Cardiotonic Agents; Diabetes Mellitus, Experimental; Female; Heart; Heart Failure; Heart Rate; In Vitro Techniques; Male; Mice; Mice, Obese; Models, Biological; Sex Factors; Trimetazidine; Ventricular Function | 2017 |
The Beneficial Effects of Trimetazidine on Reperfusion-Induced Arrhythmia in Diabetic Rats.
Topics: Animals; Arrhythmias, Cardiac; Diabetes Mellitus, Experimental; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Trimetazidine; Vasodilator Agents | 2019 |
The Effects of Trimetazidine on QT-interval Prolongation and Cardiac Hypertrophy in Diabetic Rats.
Topics: Animals; Cardiomegaly; Catalase; Diabetes Complications; Diabetes Mellitus, Experimental; Echocardiography; Glutathione Peroxidase; Hemodynamics; Long QT Syndrome; Male; Protective Agents; Random Allocation; Rats, Sprague-Dawley; Reproducibility of Results; Superoxide Dismutase; Time Factors; Trimetazidine | 2019 |
Cardiac Effects of Trimetazidine in Diabetic Rats.
Topics: Animals; Cardiomegaly; Diabetes Mellitus, Experimental; Heart; Long QT Syndrome; Rats; Trimetazidine | 2019 |
Experimental comparison of protective characteristics of enalapril and trimetazidine in diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enalapril; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Trimetazidine | 2014 |
Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy.
Topics: Adenylate Kinase; Animals; Apoptosis; Autophagy; Blood Glucose; Catheterization; Collagen; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Diastole; Disease Models, Animal; Fibrosis; Glucose Intolerance; Insulin; Male; Phosphorylation; Rats, Sprague-Dawley; Signal Transduction; Trimetazidine; Ventricular Dysfunction, Left | 2016 |
Trimetazidine has protective effects on spermatogenesis in a streptozotocin-induced diabetic rat model.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Male; Protective Agents; Rats; Rats, Sprague-Dawley; Spermatogenesis; Testis; Trimetazidine | 2017 |
[Effects of Trimetazidine upon ventricular remodeling and GLUT4 in diabetic rats after myocardial infarction].
Topics: Animals; Diabetes Mellitus, Experimental; Glucose Transporter Type 4; Male; Myocardial Infarction; Rats; Rats, Wistar; RNA, Messenger; Trimetazidine; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Differential effects of trimetazidine on vascular smooth muscle cell and endothelial cell in response to carotid artery balloon injury in diabetic rats.
Topics: Animals; Carotid Artery Injuries; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Experimental; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Rats, Sprague-Dawley; Trimetazidine; Vasodilator Agents | 2013 |
Effect of trimetazidine treatment on the transient outward potassium current of the left ventricular myocytes of rats with streptozotocin-induced type 1 diabetes mellitus.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Fatty Acids; Glucose; Myocytes, Cardiac; Potassium Channels; Rats; Rats, Sprague-Dawley; Streptozocin; Trimetazidine; Vasodilator Agents | 2012 |
Cardiac mitochondrial alterations induced by insulin deficiency and hyperinsulinaemia in rats: targeting membrane homeostasis with trimetazidine.
Topics: Adenosine Diphosphate; Animals; Creatine Kinase; Diabetes Mellitus, Experimental; Diet; Fatty Acids; Fructose; Homeostasis; Hyperinsulinism; Insulin; Kinetics; Lipid Metabolism; Male; Membranes; Mitochondria, Heart; Oxygen Consumption; Phospholipids; Rats; Rats, Wistar; Trimetazidine; Vasodilator Agents | 2005 |
Trimetazidine-induced enhancement of myocardial recovery during reperfusion: a comparative study in diabetic and non-diabetic rat hearts.
Topics: Animals; Blood Pressure; Coronary Circulation; Diabetes Mellitus, Experimental; Heart; Humans; In Vitro Techniques; Male; Myocardium; Rats; Rats, Sprague-Dawley; Regeneration; Reperfusion Injury; Trimetazidine; Vasodilator Agents | 2006 |
The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts.
Topics: Acetyl-CoA C-Acyltransferase; Animals; Body Mass Index; Cardiac Output; Coronary Circulation; Diabetes Mellitus, Experimental; Drinking; Fatty Acids; Glucose; Heart; Heart Rate; In Vitro Techniques; Male; Myocardium; Oxidation-Reduction; Palmitic Acid; Perfusion; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Streptozocin; Trimetazidine; Tromethamine; Vasodilator Agents | 2007 |